News from sanofi A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( EuronextParis:SAN,NYSE:SNY)

Dec 12, 2014, 08:00 ET

Sanofi Pasteur Announces FDA Approval of Fluzone® Intradermal Quadrivalent (Influenza Vaccine) for Adults

 Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration...

Dec 02, 2014, 08:35 ET

Sanofi Receives FDA Approval of Priftin® (rifapentine) Tablets for the Treatment of Latent Tuberculosis Infection

 Sanofi announced today that following a priority review, the U.S. Food and Drug Administration has approved Priftin® (rifapentine) in...

Nov 19, 2014, 08:15 ET
Sanofi

Sanofi and Regeneron Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol

 Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced new detailed positive results from six Phase 3 ODYSSEY trials that...

Nov 18, 2014, 11:22 ET
Sanofi

Sanofi Names Chief Scientific Officer Gary Nabel as Sanofi Ebola Response Coordinator

As part of its contribution to the global response to the Ebola epidemic, Sanofi announced today that it has appointed Chief Scientific Officer Dr....

Nov 03, 2014, 08:30 ET
Sanofi Pasteur Logo

Sanofi Pasteur Announces FDA Approval of Updated Prescribing Information for Fluzone® High-Dose Vaccine for Adults 65 and Older

 Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration...

Oct 28, 2014, 08:34 ET
Infographic

Sanofi: Sanofi Delivers Business EPS Growth of 10.3% at CER

Sanofi (NYSE: SNY; EURONEXT: SAN) Q3 2014 Change (reported) Change (CER) Net...

Oct 28, 2014, 03:13 ET

Sanofi - Résultats T3 2014 : Interview du Directeur Financier Jérôme Contamine

Sanofi, un leader mondial et diversifié de la santé, publie ses résultats pour le troisième trimestre 2014. Le Directeur...

Oct 28, 2014, 03:00 ET

Sanofi Q3 2014 Results - Interview with Jérôme Contamine

Sanofi, a global and diversified healthcare leader, reports results for the third-quarter of 2014. Jérôme Contamine, Chief Financial...

Oct 15, 2014, 13:00 ET

Presenta Sanofi campaña para prevenir osteoartritis en rodillas

La osteoartritis (OA) es una de las primeras 10 causas de invalidez total en México, lo que incrementa la carga económica y social del...

Oct 15, 2014, 08:00 ET

New Survey Finds Differences In Attitudes About Diabetes Based On Age

 Sanofi US announced today the findings of a new survey that reveals striking differences in opinion among various age groups about diabetes...

Sep 17, 2014, 08:34 ET
Sanofi logo.  (PRNewsFoto/Sanofi)

Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease

Sanofi (EURONEXT: SAN and NYSE: SNY) and MyoKardia, Inc., a privately-held company leading the development of precision therapies for genetic...

Sep 10, 2014, 11:00 ET

Sanofi Announces $2.5 Million Contribution to Dementia Research

Major five-year grant with Canadian Consortium on Neurodegeneration in Aging (CCNA) will fund transformative research into disease prevention and...

Sep 08, 2014, 14:14 ET

FDA Approves Use of Menactra® Vaccine for Booster Immunization Against Potentially Deadly Disease

 Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration...

Sep 02, 2014, 12:05 ET
Sanofi (PRNewsFoto/Sanofi and Regeneron Pharm...)

Sanofi and Regeneron Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014

 Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced detailed positive results from four...

Aug 13, 2014, 17:00 ET
Sanofi Pasteur Logo (PRNewsFoto/Sanofi Pasteur)

Sanofi Pasteur Announces Publication of Positive Data for Fluzone® High-Dose Vaccine in The New England Journal of Medicine

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that The New England Journal of Medicine published...

Aug 12, 2014, 08:50 ET
Colorectal Cancer: Early Diagnosis is Key (PRNewsFoto/Sanofi US)

Sanofi Launches Authorized Generic Version of Eloxatin® (oxaliplatin injection)

 Sanofi US announced today that it has launched an authorized generic version of Eloxatin® (oxaliplatin injection) through Winthrop US,...

Aug 11, 2014, 07:00 ET

Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin

Sanofi (EURONEXT: SAN and NYSE: SNY) and MannKind Corporation (Nasdaq: MNKD) announced today that they have entered into a worldwide exclusive...

Aug 05, 2014, 12:28 ET
Sanofi logo.  (PRNewsFoto/Sanofi)

Sanofi: Solid Sales and Business EPS Growth at CER

 Sanofi (NYSE: SNY; EURONEXT: SAN)   Q2 2014 Change (reported) Change (CER) Net...

Jul 31, 2014, 08:00 ET
Sanofi logo.  (PRNewsFoto/Sanofi)

Sanofi: Solid Sales and Business EPS Growth at CER

 Sanofi (NYSE: SNY; EURONEXT: SAN)   Q2 2014 Change (reported) Change (CER) Net...

Jul 31, 2014, 02:28 ET

Sanofi H1 2014 Results - Interview with Chris Viehbacher

Sanofi, a global and diversified healthcare leader, reports results for the first half of 2014. Chris Viehbacher, CEO of Sanofi, comments on...